logo
Open letter to federal leaders from Manitoba researchers gets support from hundreds of Canadian academics

Open letter to federal leaders from Manitoba researchers gets support from hundreds of Canadian academics

CBC15-04-2025
Social Sharing
An open letter from a group of Manitoba researchers has garnered support from hundreds of other scientists and academics across the country, sounding the alarm about the effects of research cuts in the U.S. on Canadian research and urging federal political leaders to take action.
The letter, which was shared Friday and as of Tuesday afternoon had more than 750 signatures, said it comes "at a critical moment for global science."
"The dramatic dismantling of research infrastructure in the United States, the world's historical leader in scientific investment, has left an international innovation vacuum," it says.
Julie Lajoie, an assistant professor at the University of Manitoba and one of the academics who wrote the letter, said the current climate in the U.S. has created "a unique moment in time" in the opportunity it presents for Canada to step up to fill the research gap.
"We cannot rely anymore just on our neighbour…. We need to take our spot and we need to take our place," said Lajoie, whose research includes infectious diseases like HIV.
"And [to be] able to do that, we need to have the government to finally see that science is important, research is important."
The letter says layoffs and program cuts under U.S. President Donald Trump's administration in areas including pathogen surveillance, climate resilience, vaccine development, occupational health, cancer research and women's health at major health and environmental agencies in the U.S. "jeopardize the scientific and public health security of every country that has benefited from U.S. leadership and collaboration."
That includes cuts to funding for biomedical research at the National Institutes of Health, which supports more than 300,000 scientists, and layoffs at the Environmental Protection Agency's research office and the National Oceanic and Atmospheric Administration.
Researcher warns of 'spillover effect'
Paul Marcogliese, an assistant professor of biochemistry and medical genetics at the University of Manitoba who was among those who signed the open letter, said maintaining the status quo for research funding in Canada would represent "a degradation of our science," partly given how intertwined Canadian research is with funding or collaborators in the U.S.
"There's already colleagues of mine where that funding has been put at a standstill. And then there are also folks that are, of course, collaborating with Americans. So there's a spillover effect of our research funding decreasing," Marcogliese said.
"Certainly, five to 10 years down the line, if nothing changes from what's happening, we're all going to be further and further behind."
While the U.S. research climate provides an opportunity for scientists to bring their expertise to Canada, the letter says "a significant investment" in Canadian research is desperately needed "to capture this opportunity."
"If we want to attract those American scientists, we need to provide them the funding to do that," Lajoie said. "Right now, funding in Canada is so limited."
Among those who signed the letter was at least one U.S.-based academic: Zen Faulkes, a biology instructor at Germanna Community College in Fredericksburg, Va., who's originally from Canada and described the last few months as "catastrophic for American science."
Faulkes said while those changes make him think it would be "nice to go home, for both personal and professional reasons," he hopes to see more discussion about Canada's plan to improve its research funding so there are more opportunities for scientists like him interested in potentially moving north of the border.
"I'm not going to say that I would just take any job that opened itself up because, you know, moving is always a complex proposition. But boy … I would welcome the opportunity to look at some offers," Faulkes said. "An offer from Canada would weigh very, very strongly in my consideration."
Calls for funding increases
The letter urges the federal government to raise spending on science and technology to 1.25 per cent of Canada's GDP, a change it says needs to include a doubling of funding for what's known as the tri-council agencies responsible for the country's research funding: the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council and the Social Sciences and Humanities Research Council.
It also calls for a research accelerator fund to be established "to match and incentivize provincial, business, and non-profit investments in direct research and research infrastructure," and for the government to remove the cap on international students.
"We get requests nearly every day by e-mail from all over the world, from highly trained individuals that would like to pursue graduate studies with us," said Marcogliese. "There shouldn't be a cap on that, and added levels of bureaucracy for us to deal with, in trying to recruit an international graduate student."
The letter argues that research should be seen not as a cost for Canada, but as "a strategic catalyst for Canada's long-term prosperity, delivering significant returns through both economic growth and improved quality of life" — noting every dollar invested in research and development in Canada yields roughly $4 in GDP, according to findings from the Support our Science Campaign.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion
Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion

Toronto Star

time26 minutes ago

  • Toronto Star

Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion

CHICAGO and BOSTON, July 28, 2025 (GLOBE NEWSWIRE) — Eleos Health, the market leader in AI for behavioral health, announced its expansion deeper into post-acute care, bringing its trusted, purpose-built AI platform to home health, palliative care and hospice settings. At the 2025 National Alliance for Care at Home Financial Summit on July 28 in Chicago, Eleos will showcase how AI can ease documentation burdens, ensure compliance and improve care quality across the post-acute landscape. By 2034, Americans over the age of 65+ will outnumber children 18 and under. The U.S. home hospice market alone is estimated to reach over $75 billion by 2032. The already heavy documentation burden for in-home care providers will explode as these demographic trends continue unless providers can access innovative tools and solutions.

'Silent epidemic' chronic wound patients gets new hope from catalytic technology
'Silent epidemic' chronic wound patients gets new hope from catalytic technology

Ottawa Citizen

time26 minutes ago

  • Ottawa Citizen

'Silent epidemic' chronic wound patients gets new hope from catalytic technology

Article content DeZeeuw began using the salve on eight patients, choosing those 'with the most challenging wounds I have in my patient population.' The patients all had wounds that had been present for at least one year and as long as three years. There had been no improvement for at least six to 12 months. Johnson was among them. Article content After four weeks, something surprising happened. For most patients, the complex wounds began to look — and feel — different. DeZeeuw wasn't expecting to see 100 per cent healing in just four weeks, but what she saw through careful tracking was encouraging. Article content On average, the wounds in those patients decreased in size by 26 per cent. Half of the patients saw their wounds decrease by between 30 and 47.5 per cent in four weeks. One patient, who experienced extreme pain every time her dressings were changed, no longer felt pain. Article content After the initial four weeks, DeZeeuw continued using the treatment on five patients. Treatment was stopped on two others who had seen no improvement, and one patient died of unrelated causes. Article content Article content After eight weeks, the changes were even more profound. The average improvement was 49 per cent. Some wounds improved by as much as 80 per cent. Article content Johnson's chronic wound was 24 per cent smaller after four weeks and 30 per cent smaller at eight weeks — the first significant change seen in years. Article content 'I am really hopeful. These are really promising results,' DeZeeuw said. 'I am looking for the 100 per cent healed, and I wasn't expecting to see that in four weeks. But I am very hopeful that we will start to see those fully healed wounds.' Article content Those are the kinds of results that have been seen elsewhere in Canada where the product is being used. Article content In one case, a pressure injury that had been open for 13 years healed after being treated with the product for almost a year. Article content To some extent, chronic wounds are the dark secret of the health system. They can be devastating to patients and their families and cost the health care system billions every year. But they are not widely talked about. Article content Article content There are no colourful ribbons or lavish fundraisers to raise money and awareness, but they have an oversized impact on patients, their families and the health system as a whole. Article content The non-profit organization Wounds Canada calls them a silent epidemic. Article content Wound care costs the Canadian health system $12 billion a year, according to Wounds Canada. The non-profit organization estimates that between 30 and 50 per cent of all health care involves treating wounds. That includes half of all nursing visits delivered in the community. And home care is generally unable to meet the demand. Article content In a letter to Prime Minister Mark Carney in May, Wounds Canada CEO Mariam Botros urged the new government to invest more money in wound care, making sure it was available to all Canadians. She called it 'a 12-billion-dollar-a-year health and quality of life issue that will affect everyone in Canada at some point in their lives.' Better funding for training, supplies and preventative care would save Canada money in the long run, the organization says. Article content It could also change lives. Chronic wounds have been a scourge of health care for millennia; signs of pressure sores have been found in Egyptian mummies, Florence Nightingale reportedly said that a bed sore was 'generally not the fault of the disease, but of nursing.' Still, chronic wounds continue to keep millions of patients in hospital, in treatment, in discomfort and at risk. Article content Doing something to change the trajectory of chronic wounds became a mission of Julian Mulia, a chemical engineer originally from Mexico, who was inspired to look for solutions after losing both parents to chronic conditions, including managing wounds. He is chief operating officer of Calgary-based NanoTess. Co-founder Megan Leslie is CEO. Article content The company describes its salve as a catalyst that uses the body's natural healing reactions to promote faster healing and reduce inflammation. Article content Article content 'Essentially, when a body is trying to heal a wound, it's like pushing a rock up a mountain. And a lot of us don't of the energy or resources to help make that (healing) reaction go to completion, which is where you get into chronic wound territory and your body just can't heal itself,' said Larissa Lalonde, strategy lead at the company. Article content What the salve does, Lalonde said, is lower the energy it takes to heal the wound 'so that more of those healing reactions can take place faster and better.' Article content During a provincial commercialization project funded by the CAN Health Network and conducted by Alberta Health Services and the University of Calgary, integrating the product into treatment improved wound healing in chronic wounds by 57.6 per cent. Those were wounds that had not healed for an average of more than one and a half years. Article content Bruyère, which has the largest specialty wound treatment unit as well as the only complex care facility in eastern Ontario, is also part of the CAN Health Network, a federally funded agency that supports Canadian health-care innovation. Based on validation by the Alberta Health Service, it tried out the product earlier this year, and it now plans to expand its use, DeZeeuw said. Article content Article content 'My goal is to get it throughout Bruyère Health,' she said. 'It has the potential to really help a lot of people.' Other nearby hospitals and long-term care homes are also looking at it, she said, and it is being used across Canada. Article content 'To my knowledge, there has not been a really significant breakthrough that has kind of flipped wound care on its head — at least since I have been in medical training,' DeZeeuw said. 'I am hopeful that this ends up being really helpful for at least a significant proportion of patients.' Article content That includes many people in hospital beds and long-term care homes across the country suffering from chronic bed sores, diabetic foot ulcers and complex surgical incisions. In some cases, chronic wounds are keeping them bedridden or away from their homes and families. Article content 'Often you suffer alone if you are dealing with a wound,' said Lalonde of NanoTess. 'It is not something that people typically talk openly about. But, when you do start to talk about it with friends or family, you realize how widespread this issue is.'

NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants

Winnipeg Free Press

timea day ago

  • Winnipeg Free Press

NIH cuts spotlight a hidden crisis facing patients with experimental brain implants

Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn't pay to fix the problem and she sank back into a dangerous darkness. She worried for her life, asking herself: 'Why am I putting myself through this?' Seeger's predicament highlights a growing problem for hundreds of people with experimental neural implants, including those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there's no guarantee that their devices will be maintained — particularly after they finish participating in clinical trials — and no mechanism requiring companies or insurers to do so. A research project led by Gabriel Lázaro-Muñoz, a Harvard University scientist, aimed to change that by creating partnerships between players in the burgeoning implant field to overcome barriers to device access and follow-up care. But the cancellation of hundreds of National Institutes of Health grants by the Trump administration this year left the project in limbo, dimming hope for Seeger and others like her who wonder what will happen to their health and progress. An ethical quagmire Unlike medications, implanted devices often require parts, maintenance, batteries and surgeries when changes are needed. Insurance typically covers such expenses for federally approved devices considered medically necessary, but not experimental ones. A procedure to replace a battery alone can cost more than $15,000 without insurance, Lázaro-Muñoz said. While companies stand to profit from research, 'there's really nothing that helps ensure that device manufacturers have to provide any of these parts or cover any kind of maintenance,' said Lázaro-Muñoz. Some companies also move on to newer versions of devices or abandon the research altogether, which can leave patients in an uncertain place. Medtronic, the company that made the deep brain stimulation, or DBS, technology Seeger used, said in a statement that every study is different and that the company puts patient safety first when considering care after studies end. People consider various possibilities when they join a clinical trial. The Food and Drug Administration requires the informed consent process to include a description of 'reasonably foreseeable risks and discomforts to the participant,' a spokesperson said. However, the FDA doesn't require trial plans to include procedures for long-term device follow-up and maintenance, although the spokesperson stated that the agency has requested those in the past. While some informed consent forms say devices will be removed at a study's end, Lázaro-Muñoz said removal is ethically problematic when a device is helping a patient. Plus, he said, some trial participants told him and his colleagues that they didn't remember everything discussed during the consent process, partly because they were so focused on getting better. Brandy Ellis, a 49-year-old in Boynton Beach, Florida, said she was desperate for healing when she joined a trial testing the same treatment Seeger got, which delivers an electrical current into the brain to treat severe depression. She was willing to sign whatever forms were necessary to get help after nothing else had worked. 'I was facing death,' she said. 'So it was most definitely consent at the barrel of a gun, which is true for a lot of people who are in a terminal condition.' Patients risk losing a treatment of last resort Ellis and Seeger, 64, both turned to DBS as a last resort after trying many approved medications and treatments. 'I got in the trial fully expecting it not to work because nothing else had. So I was kind of surprised when it did,' said Ellis, whose device was implanted in 2011 at Emory University in Atlanta. 'I am celebrating every single milestone because I'm like: This is all bonus life for me.' She's now on her third battery. She needed surgery to replace two single-use ones, and the one she has now is rechargeable. She's lucky her insurance has covered the procedures, she said, but she worries it may not in the future. 'I can't count on any coverage because there's nothing that says even though I've had this and it works, that it has to be covered under my commercial or any other insurance,' said Ellis, who advocates for other former trial participants. Even if companies still make replacement parts for older devices, she added, 'availability and accessibility are entirely different things,' given most people can't afford continued care without insurance coverage. Seeger, whose device was implanted in 2012 at Emory, said she went without a working device for around four months when the insurance coverage her wife's job at Emory provided wouldn't pay for battery replacement surgery. Neither would Medicare, which generally only covers DBS for FDA-approved uses. With her research team at Emory advocating for her, Seeger ultimately got financial help from the hospital's indigent care program and paid a few thousand dollars out of pocket. She now has a rechargeable battery, and the device has been working well. But at any point, she said, that could change. Federal cuts stall solutions Lázaro-Muñoz hoped his work would protect people like Seeger and Ellis. 'We should do whatever we can as a society to be able to help them maintain their health,' he said. Lázaro-Muñoz's project received about $987,800 from the National Institute of Mental Health in the 2023 and 2024 fiscal years and was already underway when he was notified of the NIH funding cut in May. He declined to answer questions about it. Ellis said any delay in addressing the thorny issues around experimental brain devices hurts patients. Planning at the beginning of a clinical trial about how to continue treatment and maintain devices, she said, would be much better than depending on the kindness of researchers and the whims of insurers. 'If this turns off, I get sick again. Like, I'm not cured,' she said. 'This is a treatment that absolutely works, but only as long as I've got a working device.' ____ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store